10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) 3-Year EBITDA Growth Rate : 0.00% (As of Sep. 2023)

View and export this data going back to 2022. Start your Free Trial

What is 10X Capital Venture Acquisition III 3-Year EBITDA Growth Rate?

10X Capital Venture Acquisition III's EBITDA per Share for the three months ended in Sep. 2023 was $-0.17.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Competitive Comparison of 10X Capital Venture Acquisition III's 3-Year EBITDA Growth Rate

For the Shell Companies subindustry, 10X Capital Venture Acquisition III's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10X Capital Venture Acquisition III's 3-Year EBITDA Growth Rate Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, 10X Capital Venture Acquisition III's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where 10X Capital Venture Acquisition III's 3-Year EBITDA Growth Rate falls into.

10X Capital Venture Acquisition III 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

10X Capital Venture Acquisition III (AMEX:VCXB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

10X Capital Venture Acquisition III 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of 10X Capital Venture Acquisition III's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » 10X Capital Venture Acquisition Corp III (AMEX:VCXB) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

BCSA LCW GAQ FLME CHEA EVE HCMA SUAC ALCY HHLA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA

Traded in Other Exchanges

N/A

Address

1 World Trade Center, 85th Floor, New York, NY, USA, 10007

Website

https://www.10xspac.com

10X Capital Venture Acquisition Corp III is a blank check company.

Executives

Kash Sheikh	director	4001 KENNETT PIKE, SUITE 302, WILMINGTON DE 19807
Woodrow Levin	director	535 MISSION STREET, 11TH FLOOR, SAN FRANSISCO CA 941105
Christopher Jurasek	director	13625 TECHNOLOGY DR, EDEN PRAIRIE MN 55344-2252
Oliver Wriedt	officer: See Remarks	CIFC CORP., 250 PARK AVENUE, 4TH FLOOR, NEW YORK NY 10177
David Weisburd	director, officer: COO & Head of Origination	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Guhan Kandasamy	officer: Chief Financial Officer	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Hans Thomas	director, 10 percent owner, officer: Chief Executive Officer	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Boris Silver	director	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
10x Capital Advisors, Llc	10 percent owner	1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
10x Capital Spac Sponsor Iii Llc	director, 10 percent owner	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NJ 10007

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Headlines

From GuruFocus

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

By GlobeNewswire • 08-10-2023